Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.

Mol Cell Biol

Laboratoire de Génétique Oncologique, Institut Gustave Roussy, 94805 Villejuif, France.

Published: February 2004

The transcription factors MyoD and Myf-5 control myoblast identity and differentiation. MyoD and Myf-5 manifest opposite cell cycle-specific expression patterns. Here, we provide evidence that MyoD plays a pivotal role at the G(2)/M transition by controlling the expression of p21(Waf1/Cip1) (p21), which is believed to regulate cyclin B-Cdc2 kinase activity in G(2). In growing myoblasts, MyoD reaccumulates during G(2) concomitantly with p21 before entry into mitosis; MyoD is phosphorylated on Ser5 and Ser200 by cyclin B-Cdc2, resulting in a decrease of its stability and down-regulation of both MyoD and p21. Inducible expression of a nonphosphorylable MyoD A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the p21 promoter. MyoD A5/A200 causes sustained p21 expression, which inhibits cyclin B-Cdc2 kinase activity in G(2) and delays M-phase entry. This G(2) arrest is not observed in p21(-/-) cells. These results show that in cycling cells MyoD functions as a transcriptional activator of p21 and that MyoD phosphorylation is required for G(2)/M transition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC344165PMC
http://dx.doi.org/10.1128/MCB.24.4.1809-1821.2004DOI Listing

Publication Analysis

Top Keywords

cyclin b-cdc2
12
myod
11
delays m-phase
8
m-phase entry
8
myod myf-5
8
g2/m transition
8
b-cdc2 kinase
8
kinase activity
8
myod a5/a200
8
p21
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!